LCLei Chen

Lei Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lei Chen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual-agonist-loaded hydrogel for STING/TLR-mediated immunotherapy against tumor recurrence and metastasis

    by Lei Chen, Lijie Wang, Liqun Li, Jianfeng Mu, Jiandong Tai, Haochen Yao

    Tumor recurrence and metastasis following surgery remain major clinical challenges, largely due to residual lesions and immunosuppressive tumor microenvironment (TME). This work describes the development of a biodegradable hydrogel (PSR-Gel) based on oxidized sodium alginate and carboxymethyl chitosan co-loaded with R848 (a TLR7/8 agonist) and SR717 (a STING agonist) for localized postoperative immunotherapy. PSR-Gel exhibited a uniform porous structure, sustained drug release (~10 days), gradual in vivo degradation (~9 days), and excellent biocompatibility. In addition, it efficiently activated bone marrow-derived dendritic cells in vitro through a synergistic activation of the TLR7/8 and STING pathways. PSR-Gel used in a CT26 colon cancer model achieved a tumor suppression rate (TSR) of 94.33% with negligible toxicity, while remodeling the TME by modulating immune cell subsets. The combination treatment with αPD-L1 used in 4T1 breast cancer model resulted in a TSR of 97.87% and a cure rate of 83.33%, with survival exceeding 80 days. Moreover, PSR-Gel + αPD-L1 inhibited distant metastasis (TSR = 92.94% for secondary tumors) and prevented recurrence by inducing long-term immune memory, as evidenced by increased Tcm and Tem cell populations. Overall, this localized dual-agonist delivery system synergizes with immune checkpoint blockade to eliminate residual tumors, remodel the TME, and induce durable antitumor immunity, representing a promising and translatable strategy for postoperative cancer immunotherapy.

  • Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials

    by Ruitong Gao, Yujia Tao, Changli Zhou, Jinwei Li, Xige Wang, Lei Chen, Feng Li, Lirong Guo

    Background: Exercise therapy has shown significant efficacy as a means of treating various intestinal diseases, but its role in the treatment of constipation is still unclear. The purpose of this study was thus to analyze the effects of exercise on constipation by means of a systematic review and meta-analysis. Methods: PubMed, Web of Science, EMBASE, Cochrane Library and three Chinese databases [Wanfang Database, Chinese Biomedical Literature (CBM) and China National Knowledge Infrastructure (CNKI)] were searched for relevant studies published through June 2018. Eligible studies were selected in accordance with the PRISMA statement. The main results of interest were changes in gastrointestinal symptoms. Results: A total of nine randomized controlled trials involving 680 participants were included. Eight studies involved aerobic exercise and only one study involved anaerobic exercise. The aerobic exercises included were Qigong, walking and physical movement. The results of this systematic review and meta-analysis indicated that exercise had significant benefits as a means of improving the symptoms of constipation patients [relative risk (RR) = 1.97; 95% CI: 1.19, 3.27; p = .009; I2=91.3%]. Subgroup analyses showed that aerobic exercise (RR = 2.42; 95% CI: 1.34, 4.36; p = .000; I2=88%) similarly had a positive effect on constipation. However, these results were associated with a high risk of bias. Conclusion: Our results suggest that exercise may be a feasible and effective treatment option for patients with constipation. However, due to methodological shortcomings, the real effect of this intervention cannot be definitively determined. Researchers should, therefore, design more rigorous studies in order to evaluate the effect of exercise on constipation.


  • Open Access

    Omentin-1 promotes the growth of neural stem cells via activation of Akt signaling

    by Li-Rong Zhao, Yu-Jun DU, Lei Chen, Zhi-Gang Liu, Xiao-Yan Jia, Yue-Hai Pan, Jian-Feng Liu, BIN Liu

    Omentin is a novel adipokine, which is expressed in and released from omental adipose tissue. In the present study, the effect of omentin on neural stem cells (NSCs) was investigated. NSCs are a subtype of stem cell in the nervous system, which are able to self‑renew and generate neurons and glia for repairing neural lesions. Mouse NSCs were isolated and cultured in vitro. Treatment with recombinant omentin for 3 and 5 days significantly increased the size of NSC neurospheres (P<0.01) and enhanced NSC cell viability in normal conditions. In addition, omentin protected against the decrease in cell viability induced by the pro‑inflammatory cytokine tumor necrosis factor‑α. In the NSCs, incubation of omentin for 2, 4, 6, 8 and 16 h enhanced the phosphorylation of Akt at the Thr308 site and of AS160 at the Ser318 site, peaking 6 h after treatment. Additionally, treatment with LY294002 (10 µM), a specific inhibitor of phosphatidylinositol 3‑kinase/Akt signaling, eliminated the omentin‑induced increase in neurosphere size and cell viability. Overall, the present study provided the first evidence, to the best of our knowledge, that omentin promotes the growth and survival of NSCs in vitro through activation of the Akt signaling pathway. These results may contribute to the understanding of the role of omentin in the nervous system.